Robert L. Camp, M.D., Ph.D.



Associate Research Scientist in Pathology.


Department of Pathology
Yale University School of Medicine
P.O. Box 208023
310 Cedar Street, BML112
New Haven, CT 06520-8023

Office: (203) 737-4205
Lab: (203) 737-4205
Fax:

email: robert.camp@yale.edu


Training:
1983 - 1987 B.A., Swarthmore College
1987 - 1992 Ph.D., Rockefeller University
1993 - 1997 M.D., Yale University
1997 - 2000 A.P. Resident, Yale-New Haven Hospital
1999 - 2000 Administrative Chief Resident, Dept of Pathology, YNHH
2000 - 2001 Postdoctoral Associate, Dept. of Pathology, Yale University
2001 - Associate Research Scientist, Dept. of Pathology, Yale University


Expertise:
Quantitative Pathology

Research Interests:
Prognostic markers in breast cancer
Phenotypic differences between primary and metastatic breast cancer
Tissue microarrays
Automated analysis of immunohistochemistry
Bioinformatics & biostatistics

Professional Service:
Autopsy


Other Links:

Yale Tissue Microarray Facility

Selected Publications:

Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: Validation of three-class hypothesis. Weinberger PM, Yu Z, Kountourakis P, Sasaki C, Haffty BG, Kowalski D, Merkley MA, Rimm DL, Camp RL, Psyrri A. Otolaryngol Head Neck Surg. 2009 Sep;141(3):382-389

A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. Camp RL, Neumeister V, Rimm DL. J Clin Oncol. 2008 Dec 1;26(34):5630-7.

Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells. Kluger HM, Siddiqui SF, Angeletti C, Sznol M, Kelly WK, Molinaro AM, Camp RL. Lab Invest. 2008 Sep;88(9):962-72.

Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Chung GG, Zerkowski MP, Ghosh S, Camp RL, Rimm DL. Lab Invest. 2007 Jul;87(7):662-9.

Bimodal population or pathologist artifact? Rimm DL, Giltnane JM, Moeder C, Harigopal M, Chung GG, Camp RL, Burtness B. J Clin Oncol. 2007 Jun 10;25(17):2487-8.

Classification of breast cancer using genetic algorithms and tissue microarrays. Dolled-Filhart M, Ryden L, Cregger M, Jirstr0m K, Harigopal M, Camp RL, Rimm DL. Clin Cancer Res. 2006 Nov 1;12(21):6459-68.

Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin CY, Dickson RB, Rimm DL,Camp RL. Cancer Res. 2003 Mar 1;63(5):1101-5.

Automated subcellular localization and quantification of protein expression in tissue microarrays. Camp RL, Chung GG, Rimm DL. Nat Med. 2002 Nov;8(11):1323-7.

Search PubMed Database for Robert Camp


This page was last modified on: 09/23/2009